A peer-reviewed journal that offers evidence-based clinical information and continuing education for dentists.

3M Continues Fight Against COVID-19 With Aid for Relief and Recovery Efforts

Funds help support frontline healthcare workers, vulnerable populations and medical research and development.


ST. PAUL, Minn.–(BUSINESS WIRE)–In its continued effort to combat the COVID-19 global pandemic, 3M has announced plans to provide $20 million in financial support to frontline healthcare workers, vulnerable populations disproportionately affected by the virus and medical research initiatives. 3M’s investment will be directed to community partners working to address critical needs during this global crisis.

3M is the lead sponsor for Direct Relief’s newly formed COVID-19 Fund for Community Health. The $10 million investment will provide community health centers with direct financial aid to support healthcare workers. A portion of this investment is dedicated to international markets responding to COVID-19, as prioritized by Direct Relief global insights.

Another important aspect of 3M’s giving includes funds for communities and families who have been disproportionally affected by the pandemic. 3M will donate $5 million toward United Way’s COVID-19 Community Response and Recovery Fund as the agency works to provide critical resources, including food, shelter and rent assistance to vulnerable populations around the world.

3M will also provide $5 million for COVID-19 research and development initiatives at leading education institutions in the United States and around the world. This includes $2 million for the University of Minnesota – recognizing their Medical School as a federally-designated infectious disease containment center. Science is at the heart of 3M and the company is dedicated to advancing the rapid study of this virus.

As the crisis unfolds, 3M will continue to respond with innovative and effective ways to help, which will span all of 3M’s global operations.

Leave A Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy